Phospholipid Spectrum Disorder in Psychiatry
Editors: Malcolm Peet, lain Glen, David F Horrobin 339pp Price £71.60; US $145.50 ISBN 1-871622-10-7 Carnforth: Marius Press, 1999 Schizophrenia as conceived by Bleuler was a metabolic defect that affected the brain and expressed itself in behaviour. This led to a variety of endocrine treatments as well as research on plasma protein fractions. In 1952 with the emergence of the psychotomimetic compounds, notably LSD and mescaline, a new hypothesis emerged the transmethylation hypothesis. For twenty years this was the dominant hypothesis in the field of schizophrenia, a fact that trainees in psychiatry and the public at large with an interest in nervous illnesses have almost completely forgotten. Nobel laureates and senior neuroscientists of the day endorsed the research programme generated by the transmethylation hypothesis, which evolved to include proposals about the effect of oxidative stress on nervous functioning. It gave rise to a host of widely reproduced observations on schizophrenia-notably the lack of flushing in response to niacin, the worsening of the condition in response to methionine and a range of other biological findings which have stood the test of time. These could be linked into aspects of what was known about the synthetic and degradative pathways involving neurotransmitters.
The transmethylation hypotheses were eclipsed in the 1970s by the dopamine hypothesis of schizophrenia, which stemmed from work indicating that antipsychotic drugs acted on dopamine receptors. An important change happened with this eclipse. The transmethylation hypothesis had been a coherent hypothesis about the pathogenesis of schizophrenic reactions, which did not stem from the action of the drugs used to treat the condition. It assumed that the antipsychotics were not correcting the original abnormality. In contrast the dopamine hypothesis argued, with faulty logic (as has now been conceded by its originators), that, given the utility of drugs acting on dopamine systems in the management of schizophrenia, there must be something wrong with the dopamine system in schizophrenia. Research focused on the dopamine system for almost twenty years and produced nothing of any value. It seems very clear now that, whatever the abnormality underpinning schizophrenia, it does not reside within the dopamine system. Unfortunately, trainees and many researchers have now forgotten that there were other ways to view the neurobiology of schizophrenia. In Phospholipid Spectrum Disorder in Psychiatry Malcolm Peet and his coeditors resurrect some of the older insights and supplement them with recent work in a manner that has much to commend it.
Will this back-to-the-future approach get anywhere? Probably not. One of the lessons of the dopamine story is that research and psychiatric language follow the interests of those who make money out of treating psychiatric conditions. Some of the hypotheses put forward in this book could conceivably be correct, but the world at large is unlikely to hear about them unless money can be made from the treatments that emerge. The strategy unfortunately cannot be one involving something like vitamin E, which influences phospholipid metabolism and seems beneficial in tardive dyskinesia. In the post-dopamine era the quest is for compounds that can be patented by large companies which will market them, via journals, meetings and the wider media, with a strategy that sells not only the agent but also the entity to be treated and a biomythology about the agent. Peet and colleagues note all this in passing. Their book constitutes a brave attempt to view the neurobiology of nervous conditions in a different way. Unsympathetic readers may be irritated by the considerable overlap between different chapters, and will note that the contributions come from a small number of centres. They will also note the paucity of treatment studies reported in the book, compared with other studies on aspects of membrane function for instance. More constructively, the book can be criticized for focusing too much on interactions between phospholipid systems and older classical neurotransmitters such as the monoamines. There are a large number of neurotransmitters in the brain that until recently would never have been conceived of as such nitric oxide, carbon monoxide and d-serine for example. If the phospholipid story is to return to psychiatry it may be through some new synthesis with these other constituents of the brain.
Observations of a lack of flushing response to niacin in schizophrenia and the deterioration after methionine loading remain unexplained after forty years. They have been joined more recently by observations of associations between rapid lowering of cholesterol and aggressive and suicidal behaviour, which probably also has links to phospholipid metabolism. Will it be another forty years before we can explain these phenomena? This is not a book that trainees will need to pass exams. It is not a final answer on schizophrenia or any of the nervous disorders. But it may be of greater relevance ultimately than volumes outlining the conventional views. If you have to choose between buying yet another volume containing the orthodox view or investing in an outsider, the odds on this outsider make an investment worth considering.
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Hergest Unit, Ysbyty Gwynned, Bangor LL57 2PW, Wales, UK Medicine through the Ages with Dr Baldassare Robert Richardson 248pp Price £12.95 (hardback) ISBN 1-899163-47-6 London: Quiller Press, 1999 Medicine through the Ages with Dr Baldassare is a book you might pass by on a bookshop shelf. In doing so, you would have missed a treat. It is an excellent and unusual historical novel with an ingenious plot taking the form of an autobiography of the fictitious medic, Dr Paul Baldassare. I shall be adding it to my shelf of favourite books.
Baldassare, or Bal-sarra-uzur to give his real name, was born in the city of Kish on the Euphrates c. 2700-1500 BC, long before the rise of Babylon. He becomes a slave to Imhotep, medic, priest and vizier to Pharaoh, who, for reasons not entirely clear (but essential to the story), grants Bal-sarra-uzur the choice of dying naturally or remaining alive until humankind understands the nature of disease. With incredible lack of forethought (again essential to the story), Bal-sarra-uzur chooses the latter. From then on the plot is excellent.
Not surprisingly, Bal-sarra-uzur's life spans the centuries. Asklepios, the Greek god of healing, meets him on a misty path on Mount Olympus and seconds his son Telesphorus to assist Bal-sarra-uzur in his wanderings. Telesphorus proves a light-hearted foil to Bal-sarra-uzur, who has good reason to be morose. Telesphorus guides Balsarra-uzur down the centuries, pausing to visit worthies who took the understanding of medicine a step forward or, sometimes, a step back. Richardson's highly imaginative, subtle and humorous plot provides the reader with a memorable overview of the history of medicine. The chapters are well written and entertaining. Bal-sarra-uzur meets Hippocrates whose 'everyday conversation seems to be a series of aphorisms'. He thinks Aristotle 'one of the most restless characters he has ever encountered; always searching for facts, facts and more facts'. Bal-sarra-uzur proves to be a man of parts, helping Alexander the Great to a famous victory and almost upstaging Galen as physician to Marcus Aurelius. In more modern times he works with Larrey's flying ambulances in Napoleon's campaigns and is horrified by Laennec's cadaverous appearance at a demonstration of the stethoscope.
In the granting of immortality to Bal-sarra-uzur, the life of a priestess of Astarte was sacrificed. Her soul was espoused to Bal-sarra-uzur and her periodic reincarnation enhances the plot and adds a metaphysical dimension. The book has an attractive spiritual quality. I wondered if the author's views of Christ are reflected in his comments on the virgin birth and 'the ridiculous situation in which the god became his own enemy and was himself sacrificed to himself'. Through the story, there are many reflections on death which hold the interest and make the book stimulating. 'There are flies in paradise'. The author seems fascinated with the personification of death and quotes St Francis of Assisi, 'Praise to you my Lord, for our sister Death, for no one living can escape her'. Richardson is strangely devoted to Allatu, the voluptuous Babylonian goddess of the dead. In the powerful finale, she appears to claim a soul. 'I am feared only when men do not know me. When they know me for what I am, I am welcomed'. Richardson seems to see death as being carried across the river to peaceful oblivion.
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